ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 332488 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 332488; 2) Community: the network communities that were significantly associated with the response to NSC 332488; 3) Molecule: the relationships between components within communities and NSC 332488; 4) MDR: the compounds that were significantly associated with the NSC 332488.

NSC Compound Enrichment Correlation
NSC 649677 Null 0.0352383000003056 0.54042037
NSC 661748 [6,6'-Bibenzo[6,7]cyclohepta[1,2,3-cd]benzofuran]-4,4',8,8', 10,10'-hexol, 1,1',6,6',7,7',11b,11'b-octahydro-1,1',7,7'- tetrakis(4-hydroxyphenyl)-, [1.alpha.,6.beta.(1'R*,6'S*,7'R*),7.alpha]- 0.0352383000003056 -0.037563029
NSC 682298 Camptothecin Derivative 0.0352383000003056 0.67895373
NSC 711618 Null 0.0352383000003056 0.63142417
NSC 732830 N1-(4-fluorophenyl)-4-(1-benzyl-4-chloro-2,5-dioxo-2,5-dihyd ro-1H-3-pyrrolylamino)benzamide 0.0352383000003056 0.15737571
NSC 745103 D-Valine, N,N-dimethyl-, (1R,2E,6S,10E,11aS,13S,14aR)-4,6,7,8,9,11a,12,13,14,14a-decahydro-13-hydroxy-6-methyl-4-oxo-1H-cyclopent[f]oxacyclotridecin-1-yl ester, hydrochloride 0.0352383000003056 -0.22405427
NSC 746131 PYR-41 0.0352383000003056 0.1358185
NSC 757113 METHOTREXATE(+/-) 0.0352383000003056 0.4706333
NSC 112846 N-[p-[[(2,4-Diamino-6-quinazolinyl)methyl]amino]benzoyl]-L-aspartic acid 0.0352383000003058 0.42402747
NSC 134725 K-33 0.0352383000003058 0.70915186
Total:44  Current:32    [First] [Prev] [Next] [Last]